Israel Englander’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,119
| Closed | -$1.06M | – | 6153 |
|
|
2026
Q1 | $1.06M | Sell |
4,119
-10,539
| -72% | -$2.8M | ﹤0.01% | 4350 |
|
|
2025
Q4 | $3.61M | Sell |
14,658
-134,055
| -90% | -$28.2M | ﹤0.01% | 3372 |
|
|
2025
Q3 | $26.3M | Buy |
148,713
+136,151
| +1,084% | +$20.4M | 0.01% | 1372 |
|
|
2025
Q2 | $1.73M | Sell |
12,562
-47,826
| -79% | -$7.02M | ﹤0.01% | 4008 |
|
|
2025
Q1 | $10.9M | Buy |
60,388
+41,432
| +219% | +$6.97M | 0.01% | 2096 |
|
|
2024
Q4 | $2.97M | Sell |
18,956
-28,667
| -60% | -$5.09M | ﹤0.01% | 3321 |
|
|
2024
Q3 | $8.67M | Buy |
47,623
+45,053
| +1,753% | +$8.69M | ﹤0.01% | 2318 |
|
|
2024
Q2 | $472K | Sell |
2,570
-54,065
| -95% | -$9.08M | ﹤0.01% | 4631 |
|
|
2024
Q1 | $10.1M | Buy |
56,635
+48,114
| +565% | +$6.68M | ﹤0.01% | 2186 |
|
|
2023
Q4 | $1.06M | Buy |
+8,521
| New | +$945K | ﹤0.01% | 4117 |
|
|
2023
Q1 | – | Sell |
-15,123
| Closed | -$1.2M | – | 6612 |
|
|
2022
Q4 | $1.2M | Buy |
+15,123
| New | +$1.12M | ﹤0.01% | 3988 |
|
|
2022
Q3 | – | Sell |
-15,076
| Closed | -$1.09M | – | 7299 |
|
|
2022
Q2 | $990K | Buy |
+15,076
| New | +$938K | ﹤0.01% | 4376 |
|
|
2022
Q1 | – | Sell |
-61,429
| Closed | -$3.83M | – | 7203 |
|
|
2021
Q4 | $4.3M | Buy |
61,429
+36,619
| +148% | +$2.13M | ﹤0.01% | 3057 |
|
|
2021
Q3 | $1.29M | Buy |
+24,810
| New | +$1.47M | ﹤0.01% | 4401 |
|
|
2021
Q1 | – | Sell |
-25,544
| Closed | -$1.86M | – | 6255 |
|
|
2020
Q4 | $1.53M | Buy |
+25,544
| New | +$1.28M | ﹤0.01% | 3437 |
|
|
2020
Q3 | – | Sell |
-6,964
| Closed | -$302K | – | 4654 |
|
|
2020
Q2 | $288K | Buy |
+6,964
| New | +$335K | ﹤0.01% | 3676 |
|
|
2019
Q4 | – | Sell |
-13,954
| Closed | -$484K | – | 4438 |
|
|
2019
Q3 | $484K | Sell |
13,954
-105,975
| -88% | -$4.74M | ﹤0.01% | 3284 |
|
|
2019
Q2 | $4.83M | Buy |
119,929
+30,774
| +35% | +$1.01M | 0.01% | 1812 |
|
|
2019
Q1 | $2.93M | Buy |
+89,155
| New | +$2.1M | ﹤0.01% | 2141 |
|
|
2018
Q3 | – | Sell |
-25,764
| Closed | -$383K | – | 4107 |
|
|
2018
Q2 | $383K | Buy |
25,764
+8,566
| +50% | +$96.3K | ﹤0.01% | 3282 |
|
|
2018
Q1 | $174K | Sell |
17,198
-8,070
| -32% | -$79.6K | ﹤0.01% | 3399 |
|
|
2017
Q4 | $266K | Buy |
+25,268
| New | +$253K | ﹤0.01% | 3404 |
|
Other funds holding KRYS
ACA
SCM
Israel Englander's KRYS Position: Q2 2026 in Review
Israel Englander sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 4,119 shares — an estimated $1.06M sold.
Israel Englander first reported a position in KRYS in Q4 2017 and held it in 22 quarters. The position peaked at $26.3M in Q3 2025. 420 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.
- Israel Englander reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 4,119 Krystal Biotech shares in Q2 2026, an estimated $1.06M.
- Israel Englander first reported a position in Krystal Biotech in Q4 2017 and held it in 22 quarters.
- Israel Englander's Krystal Biotech position peaked at $26.3M in Q3 2025.
- 420 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.